Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.91
+0.36001.31%
Volume:1K
Turnover:30.31K
Market Cap:5.58M
PE:- -
High:27.94
Open:27.94
Low:27.88
Close:27.55
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.20
T/O Rate:0.54%
Dividend:0.41
Dividend Rate:1.48%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dow Jones Top Company Headlines at 9 PM ET: South Korea's Hanwha Makes $1 Billion Push into U.S. Naval Shipbuilding | Nvidia, ...

Dow Jones
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

24H | Riot Platforms Jumps 25%; SMCI Climbs 1%; USA Rare Earth Tumbles 8%; Rocket Lab USA Drops 7%

US Overnight
·
Aug 11

Stocks to Watch: Hims & Hers, Rocket Lab, Plug Power, Babcock & Wilcox

Dow Jones
·
Aug 11

Hims & Hers Says Testosterone Outpacing All Drugs Other than Weight-Loss

Dow Jones
·
Aug 11

Hims & Hers Gets 17-Fold Explosion in Overseas Business

Dow Jones
·
Aug 11

Hims & Hers Health Testing Peptide Ingredients Ahead of Expected FDA Decision on Allowing Compounding for the Drugs - Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Expects Gross Margins to Remain Below Historical Levels, Due to International, Weight-Loss Business Expansion - Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Exec Says AI Technology to Lower Prices for Weight-Loss Subscribers in 2026- Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call

THOMSON REUTERS
·
Aug 11

Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough.

Dow Jones
·
Aug 11

Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says

Reuters
·
Aug 11

Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says

THOMSON REUTERS
·
Aug 11

Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says

THOMSON REUTERS
·
Aug 11

Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss

Dow Jones
·
Aug 11

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Benzinga Earnings
·
Aug 11

Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth

Reuters
·
Aug 11

Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss

MT Newswires Live
·
Aug 11

Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million

Reuters
·
Aug 11